Cas:159603-47-1 tert-butyl N-[(3-methylazetidin-3-yl)methyl]carbamate manufacturer & supplier

Chemical Name:tert-butyl N-[(3-methylazetidin-3-yl)methyl]carbamate

CAS.NO:159603-47-1

Synonyms:tert-Butyl [(3-methylazetidin-3-yl)methyl]carbamate;Carbamic acid, N-[(3-methyl-3-azetidinyl)methyl]-, 1,1-dimethylethyl ester;tert-Butyl-[(3-methylazetidin-3-yl)methyl]carbamat;2-Methyl-2-propanyl [(3-methyl-3-azetidinyl)methyl]carbamate

Molecular Formula:C₁₀H₂₀N₂O₂

Molecular Weight:200.278

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:288.9±13.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.458

PSA:50.36000

Exact Mass:200.152481

LogP:1.26

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like tert-Butyl [(3-methylazetidin-3-yl)methyl]carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-propanyl [(3-methyl-3-azetidinyl)methyl]carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbamic acid, N-[(3-methyl-3-azetidinyl)methyl]-, 1,1-dimethylethyl ester Use and application,Carbamic acid, N-[(3-methyl-3-azetidinyl)methyl]-, 1,1-dimethylethyl ester technical grade,usp/ep/jp grade.

Related News: He further explained that getting a new drug to commercial manufacturing is also complex and costly due to the very stringent drug manufacturing regulatory mechanism. 3-iodo-1-methylbutyl p-toluenesulfonate manufacturers A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. 3,7-dimethylocta-1,6-dien-3-yl dodecylglycinate hydrobromide suppliers Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company. rel-(1R,5S,6S)-N-(tert-butyl)bicyclo[3.2.0]hept-2-en-6-amine vendor & factory A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. ,Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company.